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Acute kidney injury (AKI) is a serious problem during pregnancy. Once occurred, it
brings about devastating maternal and fetal outcomes. Among developed nations, the
trend of pregnancy-related AKI (PRAKI) is on a decline due to the advances in obstetrics
care and the legality of abortion. On the contrary, this situation remains one of the major
health problems in the developing countries. Though some improvements have been
observed, PRAKI still causes high maternal morbidity and mortality, leading to fetal
losses. This article aims to review current studies with regards to obstetrics related AKI.
Most of the studies in this review were carried out in observational, both prospective and
retrospective, studies. Results demonstrated a variety of major PRAKI causes such as
hypertensive disorders in pregnancy, obstetric hemorrhage, sepsis, thrombotic micro-
angiopathy and acute fatty liver in pregnancy. Aside from awareness of the etiologies of
PRAKI, understanding the physiological renal adaptation during pregnancy is crucial for
early detection, diagnosis, and proper management to prevent the obstetric complications.1. Introduction
Acute kidney injury (AKI) was deﬁned as an increase in
serum creatinine within 2–7 days or oliguria. It affects 10%–
20% of hospitalized adults and is associated with an increased
risk of chronic kidney disease and further complications. The
development of AKI in pregnancy, termed pregnancy-related
AKI (PRAKI) is not rare, occurring between 6% and 55%
cases. This condition contributes as one of the most common
causes of AKI, contributing 20%–40% of all AKI cases[1]. The
mortality rate remains very high and the risks for both
maternal and fetal complications are also signiﬁcant. PRAKI
may be due to a decrease in renal perfusion or ischemic acute
tubular necrosis (ATN) from a variety of conditions. These
include hyperemesis gravidarum, postpartum hemorrhage, and
renal cortical necrosis (RCN). Other speciﬁc pregnancy-related
conditions such as preeclampsia, thrombotic microangiopathies
(TMA), and acute fatty liver of pregnancy are also the signiﬁcant
etiologies of PRAKI.2. Renal physiological changes during pregnancy
Normal pregnancy accompanies a number of physical and
psychological changes. The urinary tract is a system that dem-
onstrates remarkable alterations in both anatomy and physi-
ology. Understanding of these changes is crucial in evaluating
renal diseases in pregnant women.
2.1. Anatomical changes
Initially, the size of the kidney increases by 1.0–1.5 cm in
length[2–4]. Primarily, the change is in the collecting system[4].
This is the result of tissue hypertrophy[2], renal vascular and
interstitial space expansion[3]. The renal pelvis, calyces and
ureters are also dilated, expanding to the pelvic brim[4]. It is
postulated that nearly 90% of normal pregnant women
develop physiological hydronephrosis[2,3], with more
pronounced dilatation noted on the right kidney[2,4]. This is
probably due to the dextrorotation of the uterus and dilatation
of right ovarian venous plexus[4], as evident from
ultrasonography[2]. In addition, the gravid uterus causes partial
extrinsic mechanical obstruction of the urinary tract[2,3]. The
progesterone hormone directly exerts its effect of smooth
muscle relaxation[2,5], while prostaglandin E2 inhibits ureteric
tone and peristalsis[3]. All of these changes lead to urinary
stasis, increased risk of bacterial overgrowth, and urinary tract
infections[2,4]. These anatomic ﬁndings persist up to 12-week
post-partum before returning to the pre-pregnancy state[4,5].le under the CC BY-NC-ND license
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In terms of kidney hemodynamics, renal plasma ﬂow elevates
by 5%–70%[4], and can reach up to 85% in the second
trimester[3]. After conception, the glomerular ﬁltration rate
(GFR) increases continuously and the increment can be up to
25% at the 4th week of gestation[2]. It reaches a peak at 65%
increase from the baseline at around the 13th week of
gestation[3,4]. This consequently leads to hyperﬁltration state,
bringing other physiological changes such as an increase in
uric acid clearance, increased excretion of calcium, glycosuria,
increased ﬁltration of amino acids, and increased creatinine
clearance (Table 1). In addition to a lowered blood urea nitro-
gen (BUN) level[6], serum creatinine considerably falls to a
pregnancy range of 0.4–0.8 mg/dL[2]. Hence, a serum
creatinine level of  1.0 mg/dL, though within a normal limit
in general population, signiﬁes renal impairment in the
pregnant population and prompts further investigations[3].Table 1
Physiological changes of renal hemodynamics during pregnancy.
Increased Decreased
Uric acid clearance BUN
Excretion of glucose and calcium Serum creatinine
Filtration of amino acids Serum sodium, magnesium, and
bicarbonate2.3. Systemic hemodynamics
As early as the ﬁrst trimester, systemic vascular resistance
decreases as a result of peripheral vasodilation. The process is
due to the synthesis of nitric oxide and relaxin[2–5]. In addition,
vascular responsiveness is reduced as an effect of
norepinephrine and angiotensin II[3,5]. Endothelial prostacyclin
production, prolactin and progesterone levels are all increased[3].
Compensatory events include elevation of cardiac output by
40%–50%, the increase of resting heart rate[2,5], and the reduction
of blood pressure in the ﬁrst semester[2–4]. The drop in blood
pressure reaches a nadir of approximately 10 mmHg of the
systolic measurement in the mid-trimester before rising to-
wards the pre-pregnancy level at term[2]. Plasma expansion
results in an increase in blood volume by 50%[2–5], leading to
subsequent anemia due to hemodilution. Additionally, normal
pregnancy brings about osmotic reset due to decreased
vasopressin secretion and thirst stimulation[3]. As a result,
plasma osmolality and sodium concentration decrease.
Furthermore, an increased progesterone level leads to
hyperventilation, causing mild respiratory alkalosis, and
decreasing serum bicarbonate level with a drop of about
4 mEq/L[3–5].
2.4. Incidence of PRAKI
The incidence of PRAKI is a more common problem in the
developing nations[7,8]. In the developed nations, the lesser
incidence of this problem is due to the improvement in
antenatal care[1,7,9–11], and the reduction of septic abortion due
to its legalization[3,9]. Socioeconomic factors contributing to
PRAKI in the underdeveloped countries are mainly due to
poverty, poor obstetrics care, lack of proper healthcarefacilities and awareness of the condition, delayed referral
process, multiparity, and the increasing population number[2,7,8].
All over the world, a decline in the incidence of PRAKI was
observed over the past 50 years[9,11,12]. The incidence reduced
from 20% to 40% in the 1960s to less than 10% in the recent
years[9,13]. An increased drop in the incidence was seen in the
western countries such as countries in Europe and North
America. Some studies summarized that the incidence of
PRAKI was 1.0%–2.8% in developed nations versus 4%–26%
in developing nations[9,14,15].
In the developed nations, a study done in France demonstrated
a decrease in rate of PRAKI from 40.0% to 4.5% over a 12-year
period following the legalization of abortion[1]. Nevertheless, not
all studies reported similar results. A recent retrospective cohort
study carried out in Canada illustrated that the incidence of
obstetric AKI was elevated in both Canada and the United
States. The rate of PRAKI in Canada increased from 1.6 per
10000 deliveries in 2003 to 2.3 per 10000 deliveries in 2007.
Data from the United States also showed that the rate increased
from 2.3 to 4.5 per 10000 deliveries over a 10-year period be-
tween 1998 and 2008[12]. The reason for the growing rate of
PRAKI, that is possibly not actual incidence, might be due to
the increasing sensitivity of AKI diagnosis with close obstetric
observation, particularly in high risk pregnancy. Moreover, the
incidence of dialysis required PRAKI also declined[16].
In developing countries, a large number of studies on PRAKI
were continually carried out, mostly seen from the African and
the South Asian regions. There was some degree of improve-
ment in the incidence of PRAKI. A study from India revealed a
decrease in PRAKI incidence from 22% between 1965 and 1974
to 9% between 1981 and 1986. This was due to the availability
of medical facilities and better obstetric care. Similarly, PRAKI
in South Africa showed improvement from 25% to less than
16% over a period of 15 years[8]. A study in Turkey also
demonstrated a declination of PRAKI in relation to the
reduction in septic abortion by 30% in the last 20 years. This
was due to the improved socioeconomic situation, early
detection of PRAKI, and proper management of obstetric
complications[17,18].
2.5. Deﬁnition and diagnosis of PRAKI
For the general population, the risk, injury, failure, loss of
kidney function, and end-stage renal failure criterion was the
ﬁrst classiﬁcation system for AKI created by the Acute Dialysis
Quality Initiative in 2002. Currently, the Kidney Disease
Improving Global Outcomes created the clinical practice
guidelines for AKI. AKI was deﬁned by an increase in serum
creatinine (1.5 times the normal baseline within 7 days) or urine
output of less than 0.5 mL/kg per hour for 6 h. Subsequently, the
deﬁnition was extended to include an increase in serum creati-
nine  0.3 mg/dL within 2 days (Table 2)[19].
Unfortunately, the mentioned deﬁnition of AKI is not valid
for pregnant women due to the physiological changes during
pregnancy. The renal function evaluation by eGFR is also
inaccurate. This poses potential challenges for involving clini-
cians because the diagnostic deﬁnition is not universally
conceptualized[3]. From the previously published studies, PRAKI
was diagnosed by an acute increase in serum creatinine of 0.1–
0.5 mg/dL from baseline, a failure of serum creatinine to
decrease from baseline, or serum creatinine more than 1–
2 mg/dL[1–4,6–12,14–18,20–23].
Table 2
AKI classiﬁcations.
Guideline Serum creatinine criteria Minimum time period of AKI occurring
RIFLE Risk Increase in serum creatinine  1.5 times baseline Serum creatinine changes over 1–7 days,
sustained for more than 24 hDecrease in eGFR  25%
Injury Increase in serum creatinine  2.0 times baseline
Decrease in eGFR  50%
Failure Increase in serum creatinine  3.0 times baseline
Decrease in eGFR  75%
Absolute serum creatinine  4 mg/dL with an
acute rise of at least 0.5 mg/dL
KDIGO Stage 1 Increase in serum creatinine  1.5 times baseline Deﬁnition of AKI requires serum creatinine changes
 1.5 times baseline to have occurred within 7 days
Serum creatinine increases 0.3 mg/dL within 48 h
Increase serum creatinine  0.3 mg/dL
Stage 2 Increase in serum creatinine > 2 times baseline
Stage 3 Increase in serum creatinine  3 times baseline
Absolute serum creatinine  4 mg/dL
RIFLE: Risk, injury, failure, loss of kidney function, and end-stage renal failure; eGFR: Estimated GFR; KDIGO: Kidney Disease Improving Global
Outcomes.
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racy of two widely used eGFR formulas, the modiﬁcation of diet
in renal disease and the Cockcroft-Gault equations. The results
concluded that both formulas were inaccurate in assessing the
GFR in this particular population. While the Cockcroft-Gault
equation overestimated the GFR, the modiﬁcation of diet in
renal disease formula underestimated the real GFR value by
about 40 mL/min[3,4]. But the latter might be slightly better in
estimating GFR among the preeclampsia patients[4]. As such,
the gold standard method for GFR estimation in pregnant
women was creatinine clearance by a 24-h urine collection[3,4].
Guo et al. demonstrated a negative correlation between serum
cystatin C and 24-h urine creatinine clearance when compared
with serum creatinine and uric acid in normal pregnancies and
severe preeclampsia[24]. On the contrary, Saxena et al. reported
that the serum cystatin C did not correlate with inulin
clearance in pregnancy and postpartum women[25]. Therefore,
the use of cystatin C for measurement of GFR in pregnancy
cannot be recommended at this time[25].
Currently, there are many biomarker studies for AKI pre-
diction, but studies in the pregnant population group are limited.
Patel et al. reported that serum neutrophil gelatinase-associated
lipocalin (NGAL) level was signiﬁcantly associated with
serum creatinine in the Indian pregnant population with hyper-
tension[26]. Serum NGAL level in oliguric patients was
signiﬁcantly higher compared with nonoliguric patients. Serum
NGAL level also had a positive correlation with disease
severity including blood pressure level, BUN, serum
creatinine, and serum uric acid in hypertensive pregnant
patients[27]. Xiao et al. evaluated a combination of biomarkers
for diagnosing AKI with considerable accuracy in
preeclampsia[28]. Serum cystatin C, urine retinol-binding pro-
tein, urine NGAL and urine kidney injury molecule-1 levels in
the preeclampsia group were higher than the normal pregnancy
group. When these markers were combined, the sensitivity and
speciﬁcity for diagnosing AKI were almost 100%[28].
3. Etiologies of PRAKI
Current studies have shown a variety of major etiologies of
PRAKI. The main causes mentioned in the literature are hy-
pertensive disorders in pregnancy[12–14,21,22], TMA[17], sepsis[29],
obstetrics hemorrhages[8,11,18,30], and septic shock[7]. A number
of researches pointed out that PRAKI occurred in a bimodaldistribution[1,9,15,31,32]. The ﬁrst observed peak is between the
7th and 16th week of gestation, and the second peak is noted
between the 34th and 36th week of gestation[9,15,31].
4. Early trimester
The two main etiologies of obstetric AKI during this
trimester include pre-renal azotemia resulting from hyperemesis
gravidarum, and sepsis due to septic abortion. In hyperemesis
gravidarum, severe vomiting and poor maternal intake will
trigger volume depletion, leading to AKI. Hyperemesis grav-
idarum can be diagnosed by the history of persistent vomiting
and is typically associated with metabolic alkalosis[5]. The
symptoms often aggravated by strong odors, hot food, and
delayed gastric emptying[4]. Hospitalization and supportive
treatment with intravenous ﬂuid replacement and anti-emetic
treatment are warranted in the cases of severe dehydration.
Some studies reported septic abortion as the most common
cause of PRAKI[7,9,20,29]. AKI is associated with this condition for
many reasons. Volume depletion and hypotension from
hemorrhage or sepsis may lead to considerable renal ischemia.
In addition, soap, some disinfectants, and common
abortifacients may have speciﬁc nephrotoxic effects. A study
done by Najar et al. illustrated that septic abortion accounted
for 50% of PRAKI cases, with 75% occurring in the ﬁrst
trimester and 25% in the second trimester[9]. A study carried
out in Bangladesh also showed similar results, demonstrating
that septicemia or post-abortion sepsis was the main reason of
PRAKI. In addition to irregular or absent antenatal care, low
education[7], and home births[29], most of the PRAKI patients
were from rural areas where abortions were performed by
untrained midwives[9], local village practitioners or traditional
birth attendants[20].
Furthermore, this condition is usually lethal if the causative
organism is Clostridium spp. The patient often manifests
symptoms of abdominal pain, vomiting, and jaundice, within
hours to a few days. Laboratory ﬁndings may illustrate anemia,
leukocytosis, thrombocytopenia, oliguria, and electrolyte im-
balances[4,9]. ATN is the most common ﬁnding of PRAKI and
has a good prognosis as compared to other pathological
ﬁndings[33]. Administrations of proper antibiotics, volume
resuscitation, appropriate supportive treatment, and dialysis
when indicated, are the mainstay of management to bring a
complete recovery without complications[4,34].
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5.1. Hypertensive disorders of pregnancy
Numerous studies reported this condition as the most
common cause of PRAKI[4,12–14,22]. The maternal mortality rate
was reported between 6% and 30%[14]. Predilection of
hypertensive disorders of pregnancy peaks at two settings:
young primigravida and older multiparous women. Spectrum
of hypertension disorders of pregnancy can be classiﬁed into
ﬁve categories: chronic hypertension, preeclampsia,
eclampsia, gestational hypertension and preeclampsia
superimposed on chronic hypertension. Among these entities,
studies revealed that preeclampsia and eclampsia accounted
for most of PRAKI cases. Hypertensive disorders in
pregnancy occur in about 7% of all pregnancies and it
remains the leading cause of maternal-fetal mortality. It is
also associated with intrauterine growth restriction and small
for gestational age babies[4].
Preeclampsia is deﬁned as the new onset of persistent
hypertension (systolic blood pressure  140 mmHg or diastolic
blood pressure  90 mmHg) accompanied with proteinuria
> 300 mg per day, after the 20th week of gestation[4,5,11].
Eclampsia is deﬁned as preeclampsia with the presence of
seizure[5]. Etiologies of preeclampsia are said to be multi-
factorial. Maternal risk factors can be grouped into three major
factors: obstetric factors, co-morbid factors and genetic factors
(Table 3).
The pathogenesis of preeclampsia is due to utero-placental
ischemia from a combination of genetic and environmental
factors, leading to inadequate invasion of uterine spiral arteries
by the placental trophoblast. This in turn affects the ability of
uterine vessels to transform from the high to the low resistance
channels. The ensuing placental ischemia may stimulate pro-
duction of a soluble fms-like tyrosine kinase-1 (sFlt-1). The
protein is a circulating anti-angiogenic factor that antagonizes
the angiogenic and vasodilatory effects of vascular endothelial
and placental growth factors[35]. Other factors leading to
preeclampsia include an imbalance of vasoactive substances,
endothelial dysfunction, and absence of physiologic renal
alteration seen in normal pregnancy[4].
The severity of preeclampsia is classiﬁed as mild and severe,
characterized by the blood pressure level, proteinuria, and
associated end organ damages (Table 4).
The most common presenting symptoms in preeclampsia are
epigastric or right upper quadrant pain, followed by renal
involvement, which manifests as a dropped GFR and renal
plasma ﬂow[3]. Laboratory investigations include hematocrit
level, platelet count, serum creatinine, liver aminotransferases,
serum lactate dehydrogenase (LDH), uric acid concentration,
and coagulation proﬁle. In addition, fetal monitoring tests such
as non-stress test and biophysical proﬁle should also be done[4].
Management of preeclampsia consists of maternal blood
pressure control with both pharmacological and non-
pharmacological treatment. Frequent assessment of the fetal
well-being is performed by daily fetal movement count or non-
stress test and Doppler velocimetry. Delivery is the ultimate
treatment for this condition. The decision on the timing of de-
livery is based on the gestational age, maternal and fetal con-
dition, as well as the severity of the disease itself[4]. Prompt
delivery is indicated when there is worsening maternal
condition, and signs of severe fetal distress[3].Hemolysis, elevated liver enzymes, and low platelet
(HELLP) syndrome is a variant form of severe preeclamp-
sia[3,4,11]. There is a signiﬁcant liver involvement, but nearly 20%
of affected patients have neither hypertension nor proteinuria[4].
Abnormal laboratory ﬁndings include hemolysis presenting with
anemia, decreased haptoglobin, raised LDH, elevated liver
function tests, and low platelet count[3,11]. Thrombocytopenia is
the ﬁrst abnormality to be detected and a marker of disease
severity. Approximately 70% of cases develop the disease
before delivery and it has a peak incidence between the 27th
and 37th week of gestation. In addition to elevated sFlt-1
level, soluble endoglin which is a placental-derived soluble
transforming growth factor-beta co-receptor, is also elevated. It
acts synergistically with sFlt-1 and potentiates more maternal
endothelial dysfunction[36]. The principal management of
HELLP syndrome is supportive care with timely delivery
based on gestational age and overall materno-fetal condition[11].
5.2. TMA
TMA are rare in the pregnant population. It affects about 1
per 25000 gestations. TMA in pregnancy accounts for 8%–18%
of all TMA cases[37,38]. The disease is deﬁned by the presence of
ﬁbrin and/or platelet thrombi in the microcirculation of multiple
organs, predominantly the kidney and the brain. Other
pathologic features include endothelial cell swelling,
accumulation of protein and cell debris in the subendothelial
layer of blood vessels, and splitting of the glomerular
basement membrane[3,36]. This syndrome comprises thrombotic
thrombocytopenic purpura (TTP), affecting mainly the brain;
and hemolytic uremic syndrome (HUS), affecting mainly the
kidney. Nevertheless, differentiation between the two entities
may be difﬁcult since 10% of TTP patients have signiﬁcant
AKI and neurological involvement is not uncommon in
HUS[3,5,39].
TTP is characterized by thrombocytopenia, hemolysis and a
variety of organ dysfunctions, particularly involving the renal
and neurological systems. TTP in pregnancy usually takes place
in the late trimester or during the postpartum period. The sig-
niﬁcant pathogenic feature is the gradual fall of von Willebrand
factor cleaving protease or a disintegrin and metalloproteinase
with a thrombospondin type 1 motif, member 13 as gestational
age progresses. This alters the hemostatic status during preg-
nancy. This condition is difﬁcult to differentiate from severe
preeclampsia with HELLP syndrome due to their overlapping
characteristics. The usual clinical presentation of TTP consists of
bruises, fatigue, abdominal pain, nausea, vomit, and a variety of
neurologic symptoms ranging from lethargy to seizure. Renal
involvement is found to be as high as 30%–80% in pregnancy-
related TTP, mainly presenting with proteinuria and hematuria.
The mainstay of treatment involves plasma exchanges or fresh
frozen plasma infusions, aimed to restore a signiﬁcant enzymatic
activity. This by far decreases the maternal mortality remark-
ably[11]. Systemic steroid is used as an adjunctive therapy, but no
deﬁnite evidence has proven its efﬁcacy.
Pregnancy-related HUS is mainly associated with alternative
C3 convertase dysregulation[37]. It is a syndrome consisting of
microangiopathic hemolyticanemia, thrombocytopenia, and
renal failure. This condition somewhat overlaps with severe
preeclampsia accompanied by HELLP syndrome. However,
there are some distinguishing features between HUS and
HELLP syndromes. HUS is associated with the complement
Table 3
Maternal risk factors of preeclampsia.
Obstetric factors Co-morbid factors Genetic factors
Nulliparous/primigravida
Age > 35 or < 16 years
Multiple gestation pregnancy
History of preeclampsia
Molar pregnancy
Chronic hypertension
Renal disease
Rheumatic disease
Pre-existing diabetes mellitus
Obesity
Anti-phospholipid antibody
Factor V Leiden mutation
Preeclampsia in ﬁrst-degree relative pregnancy
Table 4
Classiﬁcation of preeclampsia and its characteristic features.
Characteristics Mild Severe
Blood pressure Systolic pressure  140 mmHg or diastolic
pressure  90 mmHg, on 2 occasions
6 h apart (in previously normotensive
individuals before 20 weeks of gestation)
Systolic pressure  160 mmHg or diastolic
pressure  110 mmHg, on 2 occasions 6 h apart
Proteinuria (24-h collection)  300 mg  5 g
Associated symptoms No evidence of end-organ damage Epigastric or right upper quadrant pain and/or impaired
liver function
Visual disturbances
Persistent headache
Altered sensorium
Ankle edema
Pulmonary edema
Thrombocytopenia (platelet < 100000)
Oliguria (urine output < 400 mL/day)
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the postpartum period and there is an isolated increase of
LDH. Elevated transaminases are found in preeclampsia and
HELLP syndrome. Additionally, prolonged prothrombin time
and partial thromboplastin time are more suggestive of
preeclampsia. The treatment of HUS is plasma exchange,
aiming to remove the dysfunctional complement cascade
components and supply normal complement regulatory factors[1].
5.3. Acute fatty liver of pregnancy (AFLP)
AFLP is an infrequent complication and typically occurs after
the 34th week of gestation[5], it is counted as an obstetrics
emergency condition[1,3]. The condition is more commonly
observed in the nullipara and primigravida[4]. The incidence is
between 1 per 7000 gestations to 1 per 20000 gestations.
Several studies reported that maternal and perinatal mortality
rate is between 10% and 20%[3]. Being autosomal recessive, an
erroneous gene causes excessive fetal fatty acid accumulation
and its release into the maternal circulation. Such fatty acid
deposits in the maternal hepatic tissue and impairs the liver
function[3,4]. The histological ﬁnding illustrates microvascular
fatty inﬁltration of hepatocytes without inﬂammation or
necrosis[3,5].
The diagnosis is based on clinical and laboratory ﬁndings.
During the late trimester, pregnant women may manifest with
abdominal pain, nausea, vomit, malaise, anorexia, and jaun-
dice[3,5,11]. The severity of liver impairment varies, ranging from
moderate isolated transaminase elevations to fulminant hepatic
failure with encephalopathy. In addition, kidney involvement
that clinically resembles hepato renal syndrome can be
presented in around 60% of patients[1]. Acute kidney
dysfunction is typically nonoliguric, whereby proteinuria and
peripheral edema are common. Fortunately, renal recoveryusually follows delivery and dialysis is rarely required.
Laboratory abnormalities include hyperbilirubinemia, normal
or elevated aminotransferase, coagulopathy, anemia and
hypoglycemia[3,5,11]. AFLP is a diagnosis of exclusion, having
to rule out viral hepatitis and biliary obstruction[11]. The
deﬁnite diagnosis is conﬁrmed with a liver biopsy[3,4].
Management is generally a supportive care and immediate
delivery with caesarean section being the preferred choice of
delivery[4]. Anemia and coagulopathy are corrected by
transfusion of blood products. Hepatic encephalopathy can be
managed with high carbohydrate, low-protein diet, and oral
lactulose[11]. Most patients will recover completely after delivery
and liver transplantation is rarely necessary.
5.4. Puerperal sepsis
Several studies demonstrated that puerperal sepsis was the
leading cause of PRAKI[15,29,31,32,40]. The rate of maternal
mortality varied between 18% and 30%[40]. As deﬁned by the
World Health Organization, puerperal sepsis is a genital tract
infection occurring at any time between the rupture of
amniotic membrane and labor or 42 days postpartum. Two or
more of these conditions have to be presented: fever
( 38.5 C), pelvic pain, abnormal odor or foul-smelling
vaginal discharges, and delayed uterine involution. Major cau-
ses are prolonged rupture of membrane, obstructed labor, and
frequent vaginal examination. Sources of infection are retained
product of conception, urinary tract infection and mastitis.
Causative organisms include Gram-positive Streptococcus pyo-
genes, Staphylococcus aureus, coliform bacteria, Chlamydia
spp. and Clostridium tetani[3].
Fever and edema are also the major presentations that consist
of up to 82.4% of cases. Other clinical manifestations comprise of
dyspnea, vaginal bleeding, oliguria or anuria, changes in
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anemia, leukocytosis, thrombocytopenia, hypo/hypernatremia,
hypo/hyperkalemia, metabolic acidosis, proteinuria,
hyperbilirubinemia, and positive ﬁbrin degradation
products[15,31,32]. Management generally includes the use of
appropriate antibiotics and removal of the underlying infection[3].
5.5. Obstetrics hemorrhage
Few studies mentioned hemorrhage as a major cause of
PRAKI with postpartum hemorrhage on the lead[18,30]. Blood loss
leads to symptoms such as anuria and oliguria. The most
common clinical diagnosis was ischemic ATN[23], as a result
of hypoperfusion. The main causes of this condition are
similar to those of septicemia, including home births, delivery
by traditional birth attendants, and lack of proper facilities for
blood loss management. Intravenous volume repletion and
blood transfusion are needed to stabilize and correct the
circulatory perfusion.
5.6. RCN
RCN is a rare condition resulting from severe reduction of
renal perfusion caused by vascular spasm, microvascular injury,
or intravascular coagulation. Pregnancy complications are the
major risk factors of pregnancy-related RCN, which accounted
for nearly 50% of total RCN cases. They include placental
abruption, placenta previa, septic abortion, prolonged intrauter-
ine fetal death, and amniotic ﬂuid embolism. Patients may pre-
sent with the abrupt onset of oliguria, gross hematuria, ﬂank
pain, hypotension, vaginal bleeding, contraction of the uterus,
and symptoms of eclampsia. With imaging studies, ultrasonog-
raphy initially shows enlargement of the kidneys with reduced
blood ﬂow. CT scan is the most sensitive imaging modality. It
may reveal an absent opaciﬁcation of the renal cortex, and
enhancement of subcapsular and juxtamedullary areas and of the
medulla without excretion of contrast medium. The important
prognostic factors are the extent of necrosis, duration of oliguria,
and severity of associated conditions. The cornerstone of man-
agement is to restore hemodynamic stability, usage of dialysis as
indicated, and treatment of the underlying diseases. Unfortu-
nately, not all patients have full renal function recovery,
depending on the extent of necrosis[41].
6. Management
Management of PRAKI requires a lot of resources and in-
volves a multidisciplinary team of medical specialists, as well as
early detection and prompt intervention. Provision of care
should be executed early, timely, and correctly. Model of
PRAKI care should be targeted to the following aspects: he-
modynamic stabilization, maternal and fetal monitoring, and
treatment of underlying conditions[3,11].
Hemodynamic status can be optimized by adequate ﬂuid
replacement to correct volume deﬁcit, electrolyte correction, con-
trol of bleeding, and blood transfusion when necessary[2]. Blood
pressure should also be controlled in hypertensive pregnant
women[3]. These could minimize the progression of further
kidney damage. In certain situations, renal replacement therapy
of any modalities may be initiated. Medical indication for
dialysis remains the same as in the non-pregnant populations[2,3,6].Monitoring of maternal blood pressure, renal function tests,
and urine protein examination[5], are necessary and should be
performed frequently in order to early detect any
abnormalities. Fetal monitoring can be done by several
methods. Evaluation of the fetus at the gestational age of less
than 25 weeks is limited to Doppler auscultation. Other more
sensitive methods that can be deployed at the later age of
gestation comprise of fetal movement assessment, contraction
stress test, and biophysical proﬁle[6]. Regular fetal monitoring
is helpful in early detection of fetal distress.
Importantly, the underlying diseases should always be iden-
tiﬁed and treated. For instance, the proper use of antibiotics
according to the culture and sensitivity is essential in cases of
infection. Fluid and electrolytes repletion is warranted in those
presented with hyperemesis gravidarum. Blood transfusion
should be rendered to those with massive obstetric hemorrhage.
Management of preeclampsia is targeted to blood pressure
control, prevention of seizure, and timely delivery[2]. In TMA,
treatment with plasmapheresis is proper and efﬁcient to
increase maternal survival[1,3]. In AFLP, correction of
coagulopathy with blood components, hypoglycemic
prevention with adequate glucose administration, and hepatic
encephalopathy treatment with low-protein diet and oral lactu-
lose are all essential to stabilize the mother[3].7. Conclusions
Due to an array of systemic and physiologic renal changes,
PRAKI is a serious condition. Once occurred, it results in
devastating materno-fetal outcomes and hence, remains a critical
obstetrics complication. Apparently, its incidence is on a decline
among developed nations owing to the improvement of obstet-
rics care and the legality of pregnancy termination. Studies had
been performed to evaluate the causes of PRAKI and ﬁndings
had been extensively varied. In relation to certain gestational
periods, particular etiologies were identiﬁed accordingly. The
most common causes of PRAKI in the early trimester include
pre-renal azotemia from hyperemesis gravidarum and septic
abortion. During the late trimester, major causes of PRAKI
involve hypertensive disorders in pregnancy, TMA, AFLP and
postpartum hemorrhage. Finally, the most effective method in
dealing with this life-threatening situation is prevention. This is
done through provision and promotion of maternal education,
high-quality and accessible antenatal care with extensive ob-
stetrics facilities, early detection and diagnosis of the condition,
and timely management of obstetrics complications.
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